Abstract
We prepared FMoxLP by oxidation of FMLP and evaluated its ability to trigger a variety of granulocyte responses. FMoxLP was found to depolarize granulocyte membranes; increase granulocyte oxygen consumption, superoxide production, and hydrogen peroxide production; compete with FMLP for binding to granulocytes; and stimulate granulocyte chemotaxis. Against all of these granulocyte functions, FMoxLP was considerably less potent than the parent FMLP. When luminol-dependent-granulocyte chemiluminescence (CL) was studied, FMoxLP was observed to be a more potent stimulus of this response than FMLP. This increased CL activity of FMoxLP may be related to nonoxidative burst mechanisms. Our results indicate that FMoxLP retains a significant amount of the biological activity of FMLP (albeit in general less potent). The biological importance of the observed activities of FMoxLP must await further investigation.
Similar content being viewed by others
References
Clark, R. A. 1983. Extracellular effects of the myeloperoxidase-hydrogen peroxide-halide system.In Advances in Inflammation Research. G. Weissman, editor. Raven Press, New York. 107–146.
Jasin, H. E. 1983. Generation of IgG aggregates by the myeloperoxidase-hydrogen peroxide system.J. Immunol. 130:1918–1923.
Tsan, M. F., andDenison, R. C. 1981. Oxidation of N-formyl methionyl chemotactic peptide by human neutrophils.J. Immunol. 126:1387–1389.
Clark, R. A., andSzot, S. 1982. Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.J. Immunol. 128:1507–1513.
Williams, L. T., Snyderman, R., Pike, M. C., andLefkowite, R. J. 1977. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.Proc. Natl. Acad. Sci. U.S.A. 74:1204–1208.
Jones, G. S., Van Dyke, K., andCastranova, V. 1981. Transmembrane potential changes associated with superoxide release from human granulocytes.J. Cell. Physiol. 106:75–83.
Van Dyke, K., Peden, D., Van Dyke, C, Jones, G., Castranova, V., andMa, J. 1982. Inhibition by nonsteroidal antiinflammatory drugs of luminol dependent human granulocyte chemiluminescence and [3H]FMLP binding.Inflammation 6:113–125.
Jones, G. S., Van Dyke, K., andCastranova, V. 1980. Purification of human granulocytes by centrifugal elutriation and measurement of transmembrane potential.J. Cell. Physiol. 104:425–431.
Van Dyke, K., Van Dyke, C., Udeinya, J., Brister, C, andWilson, M. 1979. A new screening system based on chemiluminescence produced from human cells (granulocytes). Clin. Chem.25:1655–1661.
Root, R. K., Metcalf, J., Oshino, N., andChance, B. 1975. H2O2 release from human granulocytes during phagocytosis.J. Clin. Invest. 55:945–955.
Lane, T. A., Lamkin, G. C., andWindle, B. E. 1981. Phagocytosis-induced modulation of human neutrophil chemotaxis receptors.Blood 58:228–236.
Nelson, R. D., McCormack, R. T., andFiegel, V. D. 1978. Chemotaxis of human leukocytes under agarose.In Leukocyte Chemotaxis. P. G. Quie, editor. Raven Press, New York. 25–42.
Gilbertsen, R. B., Carter, G. W., andQuinn, D. J. 1980. Effects of F-Met-Leu-Phe and zymosan-activated serum on rat neutrophils in vivo.J. Reticuleondothel. Soc. 27:485–494.
Duncan, D. B. 1975.T-Tests and intervals for comparisons suggested by the data.Biometrics 31:339–359.
Clark, R. A., Szot, S., Venkatasubramanian, K., andSchiffman, E. 1980. Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine.J. Immunol. 124:2020–2026.
Snyderman, R., andGoetzl, E. J. 1981. Molecular and cellular mechanisms of leukocyte chemotaxis.Science 213:830–837.
Van Dyke, K., Matamoros, M, Van Dyke, C. J., andCastranova, V. 1983. Calcium ionophore-stimulated chemiluminescence (CL) from human granulocytes: Evidence that A23187-induced chemiluminescence originates from arachidonic acid metabolism.Microchemical J. 28:568–579.
Van Dyke, K., Castranova, V., andVan Dyke, C. J. 1983. Antiinflammatory drug effects on luminol-dependent chemiluminescence (CL) from human granulocytes stimulated by Ca++ ionophore (A23187) and by reduced or oxidized FMLP.Fed. Proc. 42:698.
Freer, R. J., Day, A. R., Raddino, J. A., Schiffman, E., Aswanikumar, S., Showell, H. J., andBecker, E. L. 1980. Further studies on the structural requirements for synthetic peptide chemoattractants.Biochemistry 19:2404–2410.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Dyke, K., Castranova, V., Van Dyke, C.J. et al. Granulocyte response to oxidized FMLP. Inflammation 8, 87–99 (1984). https://doi.org/10.1007/BF00918356
Issue Date:
DOI: https://doi.org/10.1007/BF00918356